Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy

This publication has 89 references indexed in Scilit:

• Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases
  The Lancet Oncology, 2006
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996
• Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial
  European Journal Of Cancer, 1994
• A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the north central cancer treatment group and mayo clinic
  Cancer, 1991
• A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate
  Cancer, 1990
• Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter study
  European Journal of Cancer and Clinical Oncology, 1989
• Methylprednisolone as palliative therapy for female terminal cancer patients
  European Journal of Cancer and Clinical Oncology, 1989
• Spontaneous Regression of Cerebral and Pulmonary Metastases in Renal Cell Carcinoma
  Scandinavian Journal of Urology and Nephrology, 1989
• Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial
  European Journal of Cancer and Clinical Oncology, 1986
• Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1982